Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Fulgent Genetics, |
RCV005048845 | SCV005679545 | likely pathogenic | Infantile nephronophthisis | 2024-01-10 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV005105315 | SCV005799949 | pathogenic | Nephronophthisis | 2024-02-11 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Ser721Leufs*22) in the INVS gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in INVS are known to be pathogenic (PMID: 12872123). This variant is not present in population databases (gnomAD no frequency). This variant has not been reported in the literature in individuals affected with INVS-related conditions. For these reasons, this variant has been classified as Pathogenic. |